Research on type 2 diabetes and its management. Covers nerve pain, early onset, BMI trajectories, and treatment side effects.
Researchers developed a screening technique to filter out low-quality data in wearable sensors, improving the performance of smartwatches for noninvasive blood glucose estimation. The approach enhances accuracy by discarding data with high phase errors and approximating missing values.
Researchers from NUS and Harvard T.H. Chan School of Public Health found that breastfeeding significantly reduces cardiovascular disease risk among women with type 2 diabetes and gestational diabetes. A healthy Mediterranean diet with low persistent organic pollutant exposure also lowers the risk of GDM.
Researchers developed an algorithm that splits obesity into 5 separate diagnostic profiles with contrasting risk of developing obesity complications. This can help clinicians identify individuals who need early interventions, improving disease prediction and treatment.
The use of GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors in people with type 1 diabetes has significantly increased between 2010 and 2023. This trend is driven by their benefits in weight management and cardiorenal protection, but caution is advised due to concerns about euglycemic diabetic ketoacidosis.
A low-carbohydrate diet may improve beta-cell function in people with type 2 diabetes, allowing them to better manage their disease and possibly discontinue medication. The study found that participants on a low-carb diet showed significant improvements in acute and maximal beta-cell responses compared to those on a high-carb diet.
A new study from the University of Washington found that lower-income households decreased their purchases of sweetened beverages by nearly 50%, while higher-income households reduced purchases by 18%. The tax was implemented in four U.S. cities and resulted in a significant decline in consumption among lower-income households.
Researchers from UT Arlington sequenced RNA genes of pythons, discovering conserved pathways in humans that are activated uniquely by these snakes. This knowledge helps explain intestinal regeneration and metabolism changes, offering potential therapeutic targets.
Researchers found that ultra-processed foods, including diet options, bring distinct risks for people with type 2 diabetes. Consuming more ultra-processed foods is closely linked with higher blood sugar levels, while a diet rich in minimally processed or unprocessed foods improves control.
A large study of over 3 million pregnancies found no association between paternal metformin use and risk of congenital malformations. The findings provide reassurance for clinicians in making informed treatment decisions when selecting metformin for men with type 2 diabetes who plan to have children.
A recent study analyzing data from the ANCORS-YW study found that overweight and obese women in this region are at a higher risk of hypertension and cardiovascular disease. Researchers recommend tailored preventive strategies, including lifestyle modification programs and socioeconomic support, to address this public health challenge.
A retrospective cohort study of children and adolescents found a higher risk of developing type 2 diabetes after COVID-19 infection compared to other respiratory infections. The study suggests potential long-term effects on glucose regulation.
A new treatment strategy combining ReCET and semaglutide has been shown to eliminate insulin therapy in 86% of type 2 diabetes patients, improving sensitivity to endogenous insulin. The novel procedure, which employs electroporation, is compliance-free and disease-modifying, addressing ongoing patient adherence issues.
A systematic review and meta-analysis found that weight-loss surgery reduces pancreatic cancer risk among individuals with obesity by 44%, and among those with both obesity and type 2 diabetes by 79%. The study suggests that metabolic-bariatric surgery may play a crucial role in reducing the risk of pancreatic cancer.
A new study from Karolinska Institutet found that people with type 2 diabetes have lower levels of the protein creatine kinase, leading to impaired mitochondrial function and energy production. This impairment may contribute to poorer energy metabolism in individuals with type 2 diabetes.
Studies discovered that DNA sequence changes associated with diabetes predisposition alter pancreatic cell stress response, leading to reduced insulin production and increased cell death. The findings point toward a druggable target, MAP3K5, which may help prevent or treat type 2 diabetes in high-risk individuals.
A Carnegie Mellon University-led team is developing a bioelectronic implant called ROGUE that can produce a year's supply of treatment for chronic diseases like Type 2 diabetes and obesity. The device will offer continuous, adjustable therapy deployment via a minimally invasive procedure.
A clinical trial found time-restricted eating improved blood sugar regulation and reduced markers of metabolic dysfunction in adults with metabolic syndrome. Participants who followed a customized eight-to-ten-hour eating window saw significant improvements compared to standard treatments.
A recent study found that limiting food consumption within a 10-hour window per day improved key indicators of heart health in adults with metabolic syndrome. The study demonstrated significant reductions in blood sugar and cholesterol levels, as well as lower levels of hemoglobin A1c, a marker of long-term blood sugar management.
A study suggests that semaglutide may have therapeutic value in preventing opioid overdoses by reducing the associated risk. The results require further validation, but the findings indicate a potential benefit for patients with comorbid type 2 diabetes and opioid use disorder.
Researchers at Texas A&M University have developed a method to recharge cellular mitochondria using nanotechnology, potentially extending healthy lifespans and improving outcomes for patients with age-related diseases. The molybdenum disulfide nanoparticles stimulate mitochondrial regeneration, helping cells generate more energy.
Scientists identify PICALM as a key player in regulating glucose homeostasis and insulin signaling in adipocytes. Reduced expression of PICALM improves insulin sensitivity and glucose transport, holding promise for new therapeutic approaches for type 2 diabetes and obesity.
A Mount Sinai study links prediabetes among young people with a higher likelihood of gestational diabetes and hypertensive disorders during pregnancy. The findings highlight the need for clear clinical guidance on screening and counseling youth with elevated blood glucose levels.
Researchers found that liraglutide alters iron metabolism, decreasing liver iron storage and circulation. The study suggests a potential new therapeutic option for patients with hereditary hemochromatosis.
The 2024 guideline provides comprehensive recommendations for assessing cardiovascular disease risk and managing patients taking SGLT2-inhibitors. It also highlights the importance of judicious screening and evidence-based management of cardiovascular conditions before, during, and after noncardiac surgery.
A study from the University of Copenhagen detected lipid biomarkers in obese children that indicate a higher risk of developing type 2 diabetes, liver, and heart disease later in life. A one-year lifestyle intervention lowered these biomarkers, demonstrating the importance of early intervention for children with obesity.
A Kobe University study found that the widely used casual blood glucose testing method for screening pregnant women with gestational diabetes mellitus misses 70% of cases. The researchers recommend using more reliable tests to prevent pregnancy complications and type II diabetes in mothers and children.
A study found that every 1% decrease in BMI leads to a 4% reduction in cardiovascular risk. Blood sugar control also lowers the risk of chronic kidney disease independently of weight change.
A researcher at Georgia State University has received a grant to evaluate the therapeutic potential of a new small molecule in obesity-linked diabetic models. The study aims to assess the efficacy and mechanisms of this new molecule in improving pancreatic islet cell function and mitigating adiposity.
A post-hoc analysis of the SURMOUNT trials found that tirzepatide consistently reduced body weight in both males and females, but women experienced greater weight loss with up to 24.6% reduction compared to 18.1% for men. The safety profile was broadly similar by sex, but females were more likely to experience nausea and vomiting.
The SURPASS-4 trial found that tirzepatide improved blood glucose control and weight loss in adults with type 2 diabetes. Higher doses of tirzepatide and female patients were associated with better long-term outcomes, including reduced risk of cardiovascular events.
A large-scale population analysis confirms tirzepatide's similar gastrointestinal tolerability to other GLP-1 medications without increased risk of diabetic retinopathy, medullary thyroid cancer, or pancreatitis. Researchers analyzed real-world evidence from the FDA adverse event reporting system database and found that tirzepatide has...
The study found that semaglutide was effective in preventing heart attacks and other major adverse cardiovascular events as well as death in adults with impaired kidney function. The results showed a significant reduction in cardiovascular disease risk with semaglutide, even among those with poor kidney function.
A randomized crossover trial found that restricting eating to an 8-hour window improved daily time spent in normal blood glucose range and reduced fluctuations in blood glucose levels. The benefits were evident within three days, even without restricting calories.
Research published in BMJ Open Diabetes Research & Care found a significant association between lower diligence levels and higher cardiovascular disease risk in people with type 2 diabetes. Adopting a healthy lifestyle remains beneficial regardless of diligence level.
A new class of once-weekly insulin, efsitora, is noninferior to daily insulin injections in controlling high blood sugar levels. The study found that efsitora reduced Hb1Ac by 1.26% and was associated with a lower rate of hypoglycaemia compared to daily insulin.
A Danish study published in The Journal of Dental Research found that individuals with diabetes complications are at higher risk of gum disease. Periodontitis was more common among those with microvascular complications such as retinopathy and neuropathy.
Research links impaired circadian heart rate fluctuations to microvascular disease and increased long-term risk of cardiovascular mortality in people with diabetes. Disrupted daily heart rate variations are associated with a doubled risk of dying from cardiovascular causes.
A study of 17 million individuals reveals a reciprocal relationship between asthma and type 2 diabetes, with asthma increasing T2D risk by 83% and T2D increasing asthma risk by 28%. Shared factors like hypertension and dyslipidaemia are associated with both conditions.
Researchers developed an AI model using 25 seconds of a person's voice to detect type 2 diabetes, distinguishing between individuals with high accuracy. The model showed strong performance, especially in females aged 60 or older and those with hypertension, aligning with the American Diabetes Association risk score.
Researchers have developed a semaglutide hydrogel that could reduce diabetes shots to once a month, improving drug adherence and quality of life. The hydrogel's slow release of semaglutide over one month was found to be well-tolerated in laboratory rats with no inflammatory reactions.
A study of 500,000 UK participants found insulin resistance associated with higher risk of 26 conditions, such as sleep disorders and pancreatitis, and lower risk of five diseases, including anaemia and Parkinson's disease. Insulin resistance also linked to increased mortality risk in women.
A new study in Frontiers in Nutrition found that well-constructed low-carb eating patterns can meet and sometimes exceed nutrient needs. The study assessed three different 7-day low-carb meal plans, which safely exceeded nutrient needs for vitamins A to K, thiamin, riboflavin, niacin, folate, and vitamins B6 and B12.
A cohort study found no association between GLP-1 receptor agonist use and increased risk of suicide death or related disorders in patients with type 2 diabetes. The study included mostly patients with type 2 diabetes.
Researchers in human nutrition developed an innovative tool to assign a healthy hydration recommendation score to governments, promoting water and discouraging sugary beverages. The study analyzed 93 countries with dietary guidelines, finding that 48 had complementary messages encouraging water and reducing sugary beverage intake.
Researchers used genetic method Mendelian randomization to show high levels of fasting insulin cause reduction in Lp(a), rather than the other way around. Low Lp(a) is unlikely to be a risk factor for type 2 diabetes, independent of pre-existing hyperinsulinaemia and insulin resistance.
Scientists discovered the highest natural blood sugar levels in mammals, found in a species of bats that can survive on a diet rich in sugars. The study's findings suggest that these bats have evolved unique strategies for glucose regulation, which may hold potential for managing metabolic diseases in humans.
A clinical trial found that consuming Mankai after meals can significantly lower blood sugar levels in patients with type 2 diabetes. The study showed a 20% reduction in post-meal blood sugar levels and faster return to baseline levels in about two-thirds of participants.
A new study published in Scientific Reports confirms a linear relationship between blood glucose levels and voice fundamental frequency, suggesting potential for voice-based glucose monitoring. Researchers at Klick Labs used vocal biomarkers and AI to detect Type 2 diabetes with high accuracy.
A comprehensive brain imaging study found that diabetes and prediabetes are associated with accelerated brain ageing, with brains appearing 0.5-4 years older than chronological age. A healthy lifestyle may help counteract this effect, with associations attenuated among people with high physical activity.
A simple blood test could identify individuals with type 2 diabetes who are at a higher risk of certain cancers. The study found that higher levels of pro-inflammatory cytokine interleukin-6 were associated with an increased risk of obesity-related cancers.
Researchers find that unabsorbed dietary polyphenols can reduce the risk of type II diabetes by regulating blood glucose levels and appetite through secretion of gastrointestinal hormones. Polyphenol-mediated binding and activation of T2R promotes the release of incretins, which regulate insulin secretion and food intake.
Researchers found that people with chronic diabetes complications are up to three times more likely to have a mental health condition, while those with mental health disorders are up to two and a half times more likely to experience sustained diabetes complications. The study highlights the importance of screening for both risk factors.
Researchers led by Ayyalusamy Ramamoorthy find that insulin, zinc and pH levels work together to inhibit the buildup of protein clumps contributing to Type 2 diabetes. The study offers promising avenues for innovative treatments and may revolutionize treatment approaches.
A new risk prediction scale specifically for American Indian adults found elevated heart failure rates compared to other population groups. The analysis identified Type 2 diabetes status, kidney damage, and high blood pressure as major modifiable determinants of developing heart failure over 5-10 years.
A new study from the University of Georgia found that type 2 diabetes prevalence increased by almost 20% between 2012 and 2022, affecting all sociodemographic groups. Non-Hispanic Black people were particularly hard hit, with a diabetes prevalence rate of just under 16%.
A recent study analyzing data from 1.97 million participants found that consuming 50g of processed meat a day increases type 2 diabetes risk by 15%, while eating 100g of unprocessed red meat daily raises the risk by 10%. Poultry consumption was also associated with a higher risk, but to a lesser extent.
Researchers found distinct molecular responses in skeletal muscle following bariatric surgery between obese individuals and those with additional T2D. Obesity individuals showed improvements in metabolic health, while T2D participants had limited changes.
A new study found that females' and males' muscles handle glucose and fatty acids differently, but regular physical activity cancels out these differences and triggers similar beneficial metabolic changes in both sexes. This research has important implications for preventing type 2 diabetes.
A new study found a significant association between higher heme iron intake and type 2 diabetes risk. Participants with the highest heme iron intake had a 26% higher risk of developing T2D than those in the lowest intake group. The researchers also identified key metabolic biomarkers associated with this increased risk.
A cohort study found that PTSD is a modifiable risk factor for a modest reduction in microvascular complications in veterans with comorbid PTSD and type 2 diabetes. The study suggests further research is needed to confirm findings in non-Veterans Health Administration settings.